SIGNAL TRANSDUCTION OF AMYLOID PRECURSER PROTEIN SECRETION IN NT2N CELLS
NT2N 细胞中淀粉样前体蛋白分泌的信号转导
基本信息
- 批准号:6645882
- 负责人:
- 金额:$ 19.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-01 至 2003-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer's disease Semliki Forest virus amyloid proteins biological signal transduction calcium flux cell line gene expression glutamate receptor neurons phosphorylation protein biosynthesis protein isoforms protein kinase C secretory protein synaptotagmin tissue /cell culture transfection transfection /expression vector
项目摘要
Alzheimer's disease (AD) is characterized by the deposition of beta-
amyloid (Abeta) into senile plaque, the formation of neurofibrillary
tangles, and neuronal death. The Abeta protein, a 39 to 42/43 amino acid
peptide is derived from the processing of the amyloid precursor protein
(APP) by beta- and gamma- secretases. There are three known pathways of
Abeta generation: a lysosomal/endosomal pathway, a trans-Golgi network
pathway that generates mainly extracellular Abeta/1-40, and a endoplasmic
reticulum/intermediate compartment pathway that results in the
accumulation of intracellular Abeta/1-42. In contrast, APP processed by an
alpha-secretase produces only a large secreted non-amyloidogenic
derivative (APP-S/alpha). Physiological stimuli, such as muscarinic
agonists and glutamate, increase the secretion of APP-S/alpha and decrease
extracellular Abeta production, suggesting that pharmacological
manipulation of this pathway may be of potential therapeutic benefit to
decreased the beta-amyloid load. The long-term goals of this project are
to understand in detail the molecular mechanisms involved in APP-S/alpha
secretion from NT2N neurons, and their impact on intracellular and
extracellular Abeta production. The signaling mechanisms involved in
glutamate-induced APP-S/alpha secretion are poorly understood. Our
preliminary studies show the presence of metabotropic glutamate receptors
in NT2N cells. Glutamate stimulation of NT2N neurons causes an increase in
intracellular calcium, activation of protein kinase C, and an increase in
APP-S/alpha secretion appears to require ionotropic and metabotropic
receptors, although the precise contribution of each receptor-associated
signal transduction pathway in unclear. Furthermore, increasing
intracellular calcium and/or activating protein kinase C with phorbol
esters stimulates APP-S/alpha secretion. Based on our preliminary data,
the hypothesis to be tested is that activation of protein kinase C
mediates metabotropic glutamate-induced APP-S/alpha secretion, while
calcium sensing by synaptotagmin mediates APP-S/alpha secretion induced by
increased in intracellular calcium. The general strategy used, to dissect
the components of the signaling pathways regulating APP-S/alpha secretion,
is to express each potential component of the signaling pathway (glutamate
receptor isotype, active or inactive protein kinase C isoform, active or
inactive kinase substrate, active or inactive synaptotagmin) in NT2N
neurons and measure APP-S/alpha secretion and intracellular and
extracellular Abeta production.
阿尔茨海默病 (AD) 的特点是β-沉积物
淀粉样蛋白(Abeta)转化为老年斑,形成神经原纤维
缠结和神经元死亡。 Abeta 蛋白,39 至 42/43 个氨基酸
肽源自淀粉样前体蛋白的加工
(APP) 通过 β- 和 γ- 分泌酶。已知有以下三种途径
Abeta 一代:溶酶体/内体途径,跨高尔基体网络
主要产生细胞外 Abeta/1-40 和内质
网状/中间室通路导致
细胞内 Abeta/1-42 的积累。相比之下,由 APP 处理
α-分泌酶仅产生大量分泌的非淀粉样蛋白生成
衍生物(APP-S/alpha)。生理刺激,例如毒蕈碱
激动剂和谷氨酸,增加 APP-S/alpha 的分泌并减少
细胞外 Abeta 的产生,表明药理学
操纵该途径可能具有潜在的治疗益处
减少β-淀粉样蛋白负荷。该项目的长期目标是
详细了解 APP-S/alpha 涉及的分子机制
NT2N 神经元的分泌及其对细胞内和细胞内的影响
细胞外 Abeta 的产生。涉及的信号机制
谷氨酸诱导的 APP-S/alpha 分泌知之甚少。我们的
初步研究表明代谢型谷氨酸受体的存在
在 NT2N 细胞中。 NT2N 神经元的谷氨酸刺激导致
细胞内钙、蛋白激酶 C 的激活以及
APP-S/α 分泌似乎需要离子型和代谢型
受体,尽管每个受体相关的精确贡献
信号转导途径尚不清楚。此外,增加
细胞内钙和/或用佛波醇激活蛋白激酶 C
酯类刺激 APP-S/α 分泌。 根据我们的初步数据,
待检验的假设是蛋白激酶 C 的激活
介导代谢型谷氨酸诱导的 APP-S/alpha 分泌,同时
突触结合蛋白的钙感应介导 APP-S/α 分泌
细胞内钙增加。使用的一般策略来剖析
调节 APP-S/α 分泌的信号通路的组成部分,
是表达信号通路的每个潜在成分(谷氨酸
受体同种型,活性或非活性蛋白激酶 C 同种型,活性或
NT2N 中的非活性激酶底物、活性或非活性突触结合蛋白)
神经元并测量 APP-S/α 分泌和细胞内和
细胞外 Abeta 的产生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRYAN A WOLF其他文献
BRYAN A WOLF的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRYAN A WOLF', 18)}}的其他基金
相似海外基金
Autophagy in cells upon infection with alphaviruses (Semliki Forest virus, Chikungunya virus)
感染甲病毒(塞姆利基森林病毒、基孔肯雅病毒)后细胞中的自噬
- 批准号:
248331777 - 财政年份:2013
- 资助金额:
$ 19.62万 - 项目类别:
Research Fellowships
Assessment of the Mechanism of Action and Oncolytic Potential of VA7-FAST, an Attenuated Recombinant of Semliki Forest Virus Containing the Gene for Reovirus Fusion Associated Small Transmembrane Protein, Using in Vitro and in Vivo Analyses
使用体外和体内分析评估 VA7-FAST 的作用机制和溶瘤潜力,VA7-FAST 是塞姆利基森林病毒的减毒重组体,含有呼肠孤病毒融合相关小跨膜蛋白基因
- 批准号:
183555 - 财政年份:2009
- 资助金额:
$ 19.62万 - 项目类别:
Studentship Programs
IN-SITU STUDY OF BUDDING AND ASSEMBLY OF SEMLIKI FOREST VIRUS PARTICLES
SEMLIKI 森林病毒颗粒出芽和组装的原位研究
- 批准号:
7598345 - 财政年份:2007
- 资助金额:
$ 19.62万 - 项目类别:
Untersuchungen zur Molekularbiologie der Alpha-Togaviren Sindbis Virus und Semliki Forest Virus
甲型披膜病毒辛德比斯病毒和塞姆利基森林病毒的分子生物学研究
- 批准号:
5310063 - 财政年份:1997
- 资助金额:
$ 19.62万 - 项目类别:
Research Grants
Semliki Forest Virus Rna Replicase
塞姆利基森林病毒RNA复制酶
- 批准号:
7518561 - 财政年份:1976
- 资助金额:
$ 19.62万 - 项目类别:
Continuing Grant